Journals / Türk Jinekolojik Onkoloji Dergisi / 2022 / Cilt: 22 Sayı: 2

Vulvar Melanomda c-KIT Gen Varyantı Moleküler Tedavi için Bir Şans Olabilir mi? A Variant of the c-KIT gene in Vulvar Melanoma May Be a Chance of Molecular Therapy?

Makbule Nihan Somuncu(NECMETTIN ERBAKAN UNIVERSITY)
Sıtkı Özbilgeç(NECMETTIN ERBAKAN UNIVERSITY)0000-0002-4776-4791
Emine Türen Demir(NECMETTİN ERBAKAN ÜNİVERSİTESİ)0000-0001-5510-4411
Ali Acar(NECMETTİN ERBAKAN ÜNİVERSİTESİ)0000-0002-9074-258X
Pages
13–18
Publication Date
2022-06-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to molecular genetics data, a pathogenic variant of the c-KIT gene was detected which had a therapeutic target in metastatic melanoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vulvar nodüler melanom, nadir görülen bir vulvar kanserdir.
📊
Key Findings & Data:We reported a patient with vulvar nodular melanoma who had previously been operated on breast cancer.
💡
Conclusion & Impact:According to molecular genetics data, a pathogenic variant of the c-KIT gene was detected which had a therapeutic target in metastatic melanoma.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Breast cancer · c-KIT gene · vulvar melanoma

Özet

Vulvar nodüler melanom, nadir görülen bir vulvar kanserdir. Bu vakada meme kanseri öyküsü ile opere olmuş vulvar nodüler melanomlu bir hastayı sunduk. Olgu sunumu, patoloji, tıbbi genetik ve tedavisini yönlendiren jinekoljik onkoloji tarafından derlenmiştir. Hastada, yeni nesil DNA sekans teknolojisi ile somatik mutasyon paneli çalışılmıştır. Moleküler genetik analiz sonuçlarına göre, metastatik melanomda terapötik bir hedefi olan c-KIT geninin patojenik bir varyantını tespit ettik. Vulvar nodular melanoma is a rare type of vulvar cancer. We reported a patient with vulvar nodular melanoma who had previously been operated on breast cancer. The case was prepared to share pathological and medical genetic examinations and treatment of this case with professionals dealing with oncology. We studied somatic mutation panel on biopsy material by next gene DNA sequence technology. According to molecular genetics data, a pathogenic variant of the c-KIT gene was detected which had a therapeutic target in metastatic melanoma.

🔖

Cite This Article

Somuncu, M. N., Özbilgeç, S., Demir, E. T., Acar, A. (2022). Vulvar Melanomda c-KIT Gen Varyantı Moleküler Tedavi için Bir Şans Olabilir mi? A Variant of the c-KIT gene in Vulvar Melanoma May Be a Chance of Molecular Therapy?. Türk Jinekolojik Onkoloji Dergisi, Cilt: 22 Sayı: 2, 13–18. https://ajindex.com/articles/1603043

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Referans1 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33.
  2. Referans2 Gadducci A, Carinelli S, Guerrieri ME, Aletti GD. Melanoma of the lower genital tract: Prognostic factors and treatment modalities. Gynecol Oncol. 2018;150(1):180-9.
  3. Referans3 Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman RA, Teitcher J, et al. KIT as a therapeutic target in metastatic melanoma. Jama. 2011;305(22):2327-34.
  4. Referans4 Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN. 2020;18(4):452-78.
  5. Referans5 Sugiyama VE, Chan JK, Shin JY, Berek JS, Osann K, Kapp DS. Vulvar melanoma: a multivariable analysis of 644 patients. Obstetrics & Gynecology. 2007;110(2 Part 1):296-301.
  6. Referans6 AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer discovery. 2017;7(8):818-31.
  7. Referans7 Wohlmuth C, Wohlmuth-Wieser I. Vulvar Melanoma: Molecular Characteristics, Diagnosis, Surgical Management, and Medical Treatment. Am J Clin Dermatol. 2021 Sep;22(5):639-651.
  8. Referans8 Mangana J, Levesque MP, Karpova MB, Dummer R. Sorafenib in melanoma. Expert opinion on investigational drugs. 2012;21(4):557-68.